Monitoring Agency Report for the quarter ended March 31, 2025
GRMOVER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GRM Overseas has submitted the Monitoring Agency Report from CARE Ratings covering utilization of proceeds from its preferential issue of 90.70 lakh fully convertible warrants worth Rs. 136.05 crore (allotted on August 8, 2024). As of March 31, 2025, Rs. 33.19 crore had been raised, with cumulative utilization of Rs. 33.99 crore, and only Rs. 0.05 crore left unutilized in an SBI account. In Q4 FY25, the company spent Rs. 0.80 crore on TVC production (General Corporate Purpose) — no other expenditure was reported during the quarter. The full Rs. 10 crore earmarked for inorganic growth has been deployed, while the entire Rs. 30 crore allocated for investment in subsidiary remains unspent. The report confirms no deviation from disclosed objects, no material deviation, and no major deviation compared to earlier reports.
This is a routine compliance filing confirming that warrant issue funds are being used as per the stated objects, with no red flags. The slow pace of utilization in Q4 (only Rs. 0.80 crore deployed) and the untouched Rs. 30 crore for subsidiary investment may raise mild investor questions on deployment timelines, but overall the report is neutral to positive for shareholders.